Akiro Kimura

3.0k total citations
93 papers, 2.3k citations indexed

About

Akiro Kimura is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Akiro Kimura has authored 93 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hematology, 31 papers in Molecular Biology and 26 papers in Genetics. Recurrent topics in Akiro Kimura's work include Acute Myeloid Leukemia Research (22 papers), Chronic Myeloid Leukemia Treatments (22 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers). Akiro Kimura is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Chronic Myeloid Leukemia Treatments (22 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers). Akiro Kimura collaborates with scholars based in Japan, United States and China. Akiro Kimura's co-authors include Atsushi Kuramoto, Osamu Katoh, Hironori Harada, Hideo Hyodo, Yuka Harada, Hideo Tanaka, Toshiya Inaba, Taiichi Kyo, Keichiro Mihara and Hiromasa Niimi and has published in prestigious journals such as Blood, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Akiro Kimura

90 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akiro Kimura Japan 25 1.2k 815 712 419 332 93 2.3k
Hiroo Dohy Japan 23 1.3k 1.1× 661 0.8× 493 0.7× 628 1.5× 419 1.3× 61 2.8k
Karl S. Theil United States 27 2.3k 1.8× 1.2k 1.5× 903 1.3× 449 1.1× 304 0.9× 73 3.6k
Patricia T. Greipp United States 27 972 0.8× 901 1.1× 437 0.6× 631 1.5× 292 0.9× 142 2.4k
Jean‐Louis Michaux Belgium 28 1.5k 1.3× 620 0.8× 786 1.1× 545 1.3× 195 0.6× 71 2.5k
Thomas J. Nevill Canada 25 1.8k 1.4× 471 0.6× 632 0.9× 761 1.8× 445 1.3× 99 2.5k
MF Greaves United Kingdom 16 726 0.6× 829 1.0× 320 0.4× 407 1.0× 450 1.4× 26 2.3k
Camille N. Abboud United States 27 1.6k 1.3× 810 1.0× 478 0.7× 783 1.9× 558 1.7× 109 2.7k
Bertha Frisch Israel 26 841 0.7× 529 0.6× 738 1.0× 472 1.1× 192 0.6× 72 2.2k
Stig Lenhoff Sweden 26 2.0k 1.6× 877 1.1× 365 0.5× 1.0k 2.5× 311 0.9× 87 2.7k
Henrik Hjorth‐Hansen Norway 27 1.9k 1.5× 774 0.9× 937 1.3× 859 2.1× 414 1.2× 74 2.8k

Countries citing papers authored by Akiro Kimura

Since Specialization
Citations

This map shows the geographic impact of Akiro Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiro Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiro Kimura more than expected).

Fields of papers citing papers by Akiro Kimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiro Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiro Kimura. The network helps show where Akiro Kimura may publish in the future.

Co-authorship network of co-authors of Akiro Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Akiro Kimura. A scholar is included among the top collaborators of Akiro Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiro Kimura. Akiro Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshida, Noriaki, Yoshiaki Kuroda, Yuta Katayama, et al.. (2013). Clinical Significance of sIL-2R Levels in B-Cell Lymphomas. PLoS ONE. 8(11). e78730–e78730. 46 indexed citations
2.
Mihara, Keichiro, Motoaki Ohtsubo, Shin’ichiro Yasunaga, et al.. (2011). Overexpression of BMI‐1 correlates with drug resistance in B‐cell lymphoma cells through the stabilization of survivin expression. Cancer Science. 103(1). 34–41. 27 indexed citations
3.
Mihara, Keichiro, Kazuyoshi Yanagihara, Misato Takigahira, et al.. (2009). Activated T–cell-mediated Immunotherapy With a Chimeric Receptor Against CD38 in B-cell Non-Hodgkin Lymphoma. Journal of Immunotherapy. 32(7). 737–743. 43 indexed citations
4.
Harada, Hironori, Mitsumasa Watanabe, Kenshi Suzuki, et al.. (2009). Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality. International Journal of Hematology. 90(3). 353–360. 13 indexed citations
5.
Sakai, Akira, Yoshiaki Kuroda, Yuta Katayama, et al.. (2007). Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase‐9 is not. British Journal of Haematology. 139(1). 41–50. 14 indexed citations
6.
Liu, Hong, Keichiro Mihara, Guoqi Song, Hideo Tanaka, & Akiro Kimura. (2007). Interferon-γ attenuates the survival activity of G-CSF through PI3K/Akt signaling pathway in mouse multipotent progenitor cells. Annals of Hematology. 86(8). 547–555. 6 indexed citations
7.
Kawaguchi, Hiroyuki, Hideaki Hayashi, Noriyoshi Mizuno, et al.. (2005). [Cell transplantation for periodontal diseases. A novel periodontal tissue regenerative therapy using bone marrow mesenchymal stem cells].. PubMed. 15(7). 99–104. 11 indexed citations
8.
Tanaka, Hideo, Takuo Ito, Yuta Katayama, et al.. (2005). Use of Imatinib Mesylate for Favorable Control of Hypercalcemia Mediated by Parathyroid Hormone-Related Protein in a Patient with Chronic Myelogenous Leukemia at Blast Phase. International Journal of Hematology. 82(4). 333–337. 5 indexed citations
9.
10.
Katayama, Yuta, Akira Sakai, Naohide Oue, et al.. (2003). A possible role for the loss of CD27–CD70 interaction in myelomagenesis. British Journal of Haematology. 120(2). 223–234. 28 indexed citations
11.
Taniguchi, K., et al.. (2002). Human neutrophil antigen‐2a expression on neutrophils from healthy adults in western Japan. Transfusion. 42(5). 651–657. 23 indexed citations
12.
Kuramoto, Ken, Akira Sakai, Kazushi Shigemasa, et al.. (2002). High expression of MCL1 gene related to vascular endothelial growth factor is associated with poor outcome 
in non‐Hodgkin's lymphoma. British Journal of Haematology. 116(1). 158–161. 28 indexed citations
13.
Asou, Hiroya, Adrian F. Gombart, Seisho Takeuchi, et al.. (2002). Establishment of the acute myeloid leukemia cell line Kasumi‐6 from a patient with a dominant‐negative mutation in the DNA‐binding region of the C/EBPα gene. Genes Chromosomes and Cancer. 36(2). 167–174. 24 indexed citations
14.
Fujii, Teruhisa, et al.. (2001). . Journal of the Japan Society of Blood Transfusion. 47(5). 794–795.
15.
Imamura, Nobutaka & Akiro Kimura. (2000). Effect of Ubenimex (Bestatin) on The Cell Growth and Phenotype of HL-60 and HL-60R Cell Lines: Up-and Down-Regulation of CD13/Aminopeptidase N. Leukemia & lymphoma. 37(5-6). 663–667. 7 indexed citations
16.
17.
Sakai, Akira, Kenji Oda, Hideki Asaoku, et al.. (1998). Expressions of p53 and PCNA do not correlate with the international index or early response to chemotherapy in non-Hodgkin's Lymphoma. American Journal of Hematology. 58(1). 42–48. 4 indexed citations
18.
Fujita, Keiko, et al.. (1997). Counseling on a Patient with HIV Infection. For the Improvement of the QOL.. Japanese Journal of Hospital Pharmacy. 23(6). 560–564. 1 indexed citations
19.
Katoh, Osamu, Akiro Kimura, & Atsushi Kuramoto. (1988). Platelet‐derived growth factor is decreased in patients with myeloproliferative disorders. American Journal of Hematology. 27(4). 276–280. 36 indexed citations
20.
Kimura, Akiro, Osamu Katoh, & Atsushi Kuramoto. (1988). Marrow fibroblasts from patients with myeloproliferative disorders show increased sensitivity to human serum mitogens. British Journal of Haematology. 69(2). 153–156. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroo Dohy Breakdown of academic impact, for papers by Karl S. Theil Breakdown of academic impact, for papers by Patricia T. Greipp Breakdown of academic impact, for papers by Jean‐Louis Michaux Breakdown of academic impact, for papers by Thomas J. Nevill Breakdown of academic impact, for papers by MF Greaves Breakdown of academic impact, for papers by Camille N. Abboud Breakdown of academic impact, for papers by Bertha Frisch Breakdown of academic impact, for papers by Stig Lenhoff Breakdown of academic impact, for papers by Henrik Hjorth‐Hansen
Rankless by CCL
2026